American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

Additional Metrics

Top Publications

• An Arm and a Leg: The Rising Cost of Cancer Drugs and Impact on Access.

  Natasha B Leighl;Sharon Nirmalakumar;Doreen A Ezeife;Bishal Gyawali

  (2021)
  163 Citations

• Moving Beyond 3+3: The Future of Clinical Trial Design

  Razelle Kurzrock;Chia-Chi Lin;Tsung-Che Wu;Brian P Hobbs

  (2021)
  104 Citations

• HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target

  (2022)
  94 Citations

• The GIST of Advances in Treatment of Advanced Gastrointestinal Stromal Tumor.

  (2022)
  86 Citations

• Expanding the Benefit: Dabrafenib/Trametinib as Tissue-Agnostic Therapy for BRAF V600E–Positive Adult and Pediatric Solid Tumors

  (2023)
  85 Citations

• Checkpoint Blockade in Lung Cancer With Driver Mutation: Choose the Road Wisely

  Antonio Calles;Jonathan W Riess;Julie R Brahmer

  (2020)
  82 Citations

• Disparities in Breast Cancer Associated With African American Identity.

  Erica M Stringer-Reasor;Ahmed Elkhanany;Katia Khoury;Melissa A Simon

  (2021)
  80 Citations

• Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022.

  (2022)
  77 Citations

• Assessment Criteria and Clinical Implications of Extranodal Extension in Head and Neck Cancer

  Shao Hui Huang;Rebecca Chernock;Brian O'Sullivan;Carole Fakhry

  (2021)
  72 Citations

• Best Approaches and Updates for Prostate Cancer Biochemical Recurrence.

  (2022)
  71 Citations

• Personalizing Adjuvant Endocrine Therapy for Early-Stage Hormone Receptor-Positive Breast Cancer.

  (2022)
  70 Citations

• Recent Advances in Managing Acute Lymphoblastic Leukemia.

  Daniel J DeAngelo;Elias Jabbour;Anjali Advani

  (2020)
  61 Citations

• Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment Decisions.

  (2020)
  57 Citations

• PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair

  Panagiotis A Konstantinopoulos;Stephanie Lheureux;Kathleen N Moore

  (2020)
  56 Citations